This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,288.86 and a completion date of March 26, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Firm Fixed Price Delivery Order contract, and there is no set-aside designation indicated. The contract is part of a larger Indefinite...
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,711.95 and is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,096.90 and a completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 30S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on May 13, 2025 for a ceiling value of $1,035.60. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 4, 2025. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the procurement of ENVARSUS XR 1 MG TABLET 30S, a pharmaceutical product, by the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $1,165.05 and an ultimate completion date of March 6, 2025. The contract does not have a set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, with a ceiling value of $6,847.80 and an ultimate completion date of February 27, 2025. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business designation....
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S to the Medical Supply Chain, a component of the Defense Logistics Agency (DLA). The contract, valued at $1,615.33, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and has an ultimate completion date of December 3, 2024. It is not designated as a set-aside contract....
This federal contract award is for the delivery of ENVARSUS XR 1 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The $1,216.11 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has an ultimate completion date of August 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENVARSUS XR 1 MG TABLET 100S. The award, valued at $1,288.86, is a Firm Fixed Price Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ENVARSUS XR 4 MG TABLET 100S, a specialty pharmaceutical product, with a ceiling value of $3,230.68. The contract has an ultimate completion date of April 15, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued up to $999,999,999.00 through...